CN103550524A - Medicine for treating children spastic cerebral palsy - Google Patents

Medicine for treating children spastic cerebral palsy Download PDF

Info

Publication number
CN103550524A
CN103550524A CN201310572146.9A CN201310572146A CN103550524A CN 103550524 A CN103550524 A CN 103550524A CN 201310572146 A CN201310572146 A CN 201310572146A CN 103550524 A CN103550524 A CN 103550524A
Authority
CN
China
Prior art keywords
parts
cerebral palsy
medicine
herba
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310572146.9A
Other languages
Chinese (zh)
Other versions
CN103550524B (en
Inventor
张士香
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Li Xuexin
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310572146.9A priority Critical patent/CN103550524B/en
Publication of CN103550524A publication Critical patent/CN103550524A/en
Application granted granted Critical
Publication of CN103550524B publication Critical patent/CN103550524B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicine for treating children spastic cerebral palsy. The medicine is prepared from the following substances in proportion by weight: zornia diphylla pers, indian adenosma, ipomoea cairica, elatostema oblongifolium, asparagus fern, mushroom, paphiopedilum concolor, pilea cavaleriei, kalimeris integrifolia, bamboo fungus, blowtube, botrychium virginianum, russula virescens, rabdosia adenantha and uncaria tonkinensis. The medicine for treating children spastic cerebral palsy provided by the invention is prepared from components that are all natural materials, so the medicine has good safety and clear curative effect and is suitable for large-scale promotion clinically.

Description

A kind of medicament for the treatment of infantile spasm type cerebral palsy
Technical field
The present invention relates to children nursing field, relate in particular to a kind of medicament for the treatment of infantile spasm type cerebral palsy.
Background technology
Cerebral palsy is called for short cerebral palsy, referring to and from becoming pregnant, starting the syndrome that causes to infancy stage non-carrying out property brain injury and developmental defect, and main manifestations is the dyskinesia and abnormal posture.Can be abnormal with dysnoesia in various degree, epilepsy, sensory disturbance, perceptual disturbance, communication disorder, dystropy and other.According to relevant, cerebral palsy is the gesture of rising year by year in the incidence rate of China, its disability rate is high, is one of principal disease of the current child's of causing physical disabilities, have a strong impact on child's physical and mental health and quality of life, caused great harm and financial burden to society, family and individual.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of infantile spasm type cerebral palsy.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of infantile spasm type cerebral palsy, it is to be made by the material of following weight proportioning: 2 parts of 6 parts of Herba Zornia Diphyllae, 5 parts of Herba Adenosmaes, 3 parts of ipomoea cairica, 7 parts of Elatostema oblohgifolium Fu. (Elatostema bodinier Levl), 9 parts of Herba Asparagi Setaceis, 9 parts, Lentinus Edodes, 5 parts of Philippine Paphiopedilum (Concolor Paphiopedilum), 2 parts of water stone Brassica campestris Ls, 3 parts of Kalimeris integrifolias, 7 parts of Caulis Bambusae In Taeniam, 3 parts of Ramulus Et folium Spiraeae Acuminataes, 2 parts of Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw., 8 parts of Russula vivesscens (Schaeff.) Franch., the Herba Rabdosiae Adenanthae and four stupefied logical 3 parts.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
In order to understand better the present invention, with reference to < < Chinese medicine voluminous dictionary > > second edition, being described as follows of some crude drug that use in the present invention:
Figure BDA0000414624010000021
Herba Adenosmae < < gathers medicinal herbs in the south of the Five Ridges and records > >
Medical material Ji Yuan: be the wounded in the battle herb of goatweed A. indianum.
Latin plant animal mineral name: Adenosma indianum (Lour.) Merr.
Figure BDA0000414624010000031
Russula vivesscens (Schaeff.) Franch.
Russula vivesscens (Schaeff.) Franch. is the sporophore of Mycophyta door fungus Russula vivesscens (Schaeff.) Franch..
Section belongs to classification: Russulaceae
Latin plant animal mineral name: Russula Virescens (Schaeff.) Fr.[Agari-cus virescens Schaeff.]
Figure BDA0000414624010000032
Figure BDA0000414624010000041
Whole compositions of the medicament for the treatment of infantile spasm type cerebral palsy of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, is suitable for large-scale promotion clinically.
The specific embodiment
Below by embodiment, further illustrate the present invention.It should be understood that embodiments of the invention are for the present invention rather than limitation of the present invention are described.The simple modifications that essence according to the present invention is carried out the present invention all belongs to the scope of protection of present invention.Except as otherwise noted, the percent otherwise in the present invention is percetage by weight.
Embodiment decoction of the present invention
Take 2 grams of 6 grams of Herba Zornia Diphyllae, 5 grams of Herba Adenosmaes, 3 grams of ipomoea cairica, 7 grams of Elatostema oblohgifolium Fu. (Elatostema bodinier Levl), 9 grams of Herba Asparagi Setaceis, 9 grams, Lentinus Edodes, 5 grams of Philippine Paphiopedilum (Concolor Paphiopedilum), 2 grams of water stone Brassica campestris Ls, 3 grams of Kalimeris integrifolias, 7 grams of Caulis Bambusae In Taeniam, 3 grams of Ramulus Et folium Spiraeae Acuminataes, 2 grams of Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw., 8 grams of Russula vivesscens (Schaeff.) Franch., the Herba Rabdosiae Adenanthae and four stupefied logical 3 grams, add 7000 milliliters, water, in being housed, at 80 ℃, heats 6 hours by the flask of condensing tube, filter, filtrate is decoction of the present invention.
Experimental example
Physical data
The diagnosis of 60 routine infants and typing all meet definition, diagnosis and the typing of the cerebral palsy of children that passes through of national Cerebral Palsy in Children symposium (Kunming meeting) in 2004.Male 38 examples wherein, female's 22 examples, the age is 1-4 year.
Diagnostic criteria and inclusive criteria
With reference to the diagnostic criteria passed through of national Cerebral Palsy in Children symposium (Kunming meeting) in 2004.1. meet the diagnostic criteria of doctor trained in Western medicine infantile spasm type cerebral palsy; 2. 1 years old≤age≤4 year old, male or female.
Exclusion standard
1. children with spastic age: <1 year or >4 year; 2. to the known composition allergy of this trial drug or allergic constitution patient; 3. get rid of mixed type cerebral palsy; 4. merge the serious primary disease such as cardiovascular, Liver and kidney and hemopoietic system, psychotic.
Therapeutic Method
With the decoction of preparation in embodiment 1, treat.Every day 1 time, each oral 50 milliliters, treat continuously 1 month.
Efficacy evaluation
Adopt improvement Ashworth (MAS) method carry out Ashworth score (Liu Yali, high big. the evaluation field of spasm. foreign medical science physical medicine and rehabilitation fascicle .2003.23 (2): 60-62.).MAS grading is converted into scoring, and 0 grade of muscular tension is counted 0 minute, and 1 grade of muscular tension is counted 2 minutes, and 2 grades of muscular tension are counted 3 minutes, and 3 grades of muscular tension are counted 4 minutes, and 4 grades of muscular tension are counted 5 minutes.
Curative effect determinate standard
Effective: after treatment, muscular tension recovers normal or reduces more than 2 minutes; Effective: after treatment, muscular tension reduces by 1 minute; Invalid: after treatment, muscular tension is front without improving with treatment.Total effective rate=(effective+effectively)/n * 100%.
Result
Treatment treatment is found, effective 42 examples, and effective 13 examples, invalid 5 examples, total effective rate is 91.67%.

Claims (2)

1. a medicament for the treatment of infantile spasm type cerebral palsy, it is characterized in that, it is to be made by the material of following weight proportioning: 2 parts of 6 parts of Herba Zornia Diphyllae, 5 parts of Herba Adenosmaes, 3 parts of ipomoea cairica, 7 parts of Elatostema oblohgifolium Fu. (Elatostema bodinier Levl), 9 parts of Herba Asparagi Setaceis, 9 parts, Lentinus Edodes, 5 parts of Philippine Paphiopedilum (Concolor Paphiopedilum), 2 parts of water stone Brassica campestris Ls, 3 parts of Kalimeris integrifolias, 7 parts of Caulis Bambusae In Taeniam, 3 parts of Ramulus Et folium Spiraeae Acuminataes, 2 parts of Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw., 8 parts of Russula vivesscens (Schaeff.) Franch., the Herba Rabdosiae Adenanthae and four stupefied logical 3 parts.
2. the medicament for the treatment of infantile spasm type cerebral palsy according to claim 1, is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.
CN201310572146.9A 2013-11-15 2013-11-15 Medicine for treating children spastic cerebral palsy Expired - Fee Related CN103550524B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310572146.9A CN103550524B (en) 2013-11-15 2013-11-15 Medicine for treating children spastic cerebral palsy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310572146.9A CN103550524B (en) 2013-11-15 2013-11-15 Medicine for treating children spastic cerebral palsy

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CN201410601687.4A Division CN104324234A (en) 2013-11-15 2013-11-15 Preparation method of medicament for treating infantile spastic cerebral palsy
CN201410598099.XA Division CN104324233A (en) 2013-11-15 2013-11-15 Medicament for treating infantile spastic cerebral palsy

Publications (2)

Publication Number Publication Date
CN103550524A true CN103550524A (en) 2014-02-05
CN103550524B CN103550524B (en) 2015-04-08

Family

ID=50004996

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310572146.9A Expired - Fee Related CN103550524B (en) 2013-11-15 2013-11-15 Medicine for treating children spastic cerebral palsy

Country Status (1)

Country Link
CN (1) CN103550524B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103110812A (en) * 2012-12-24 2013-05-22 原志成 Medicament for treating infantile cerebral palsy and preparation method thereof
CN103301240A (en) * 2013-07-11 2013-09-18 河南中医学院 Traditional Chinese medicine lotion for treating abnormal postures of children with spastic cerebral palsy
CN103385940A (en) * 2013-08-06 2013-11-13 河南中医学院 Traditional Chinese medicine percolate for reducing lower limb muscle tension of spastic cerebral palsy

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103110812A (en) * 2012-12-24 2013-05-22 原志成 Medicament for treating infantile cerebral palsy and preparation method thereof
CN103301240A (en) * 2013-07-11 2013-09-18 河南中医学院 Traditional Chinese medicine lotion for treating abnormal postures of children with spastic cerebral palsy
CN103385940A (en) * 2013-08-06 2013-11-13 河南中医学院 Traditional Chinese medicine percolate for reducing lower limb muscle tension of spastic cerebral palsy

Also Published As

Publication number Publication date
CN103550524B (en) 2015-04-08

Similar Documents

Publication Publication Date Title
CN102319294A (en) Double-vanilla preparation and preparation method thereof
CN101530579B (en) A pharmaceutical composition for soothing the nerves
CN103550524B (en) Medicine for treating children spastic cerebral palsy
CN102178736A (en) Medicament for treating nasosinusitis
CN103251880B (en) Pharmaceutical composition for treating tumor and preparation method thereof
CN104042994A (en) Preparation method of compound traditional Chinese medicine nasal spray
CN103845592A (en) Traditional Chinese medicine for treating cervical lymph node tuberculosis
CN103948878B (en) A kind of Chinese medicine composition for the treatment of osteopathia
CN102764377B (en) Chinese herba preparation used for treating epilepsy
CN104324234A (en) Preparation method of medicament for treating infantile spastic cerebral palsy
CN104324233A (en) Medicament for treating infantile spastic cerebral palsy
CN103272186B (en) Traditional Chinese medicine for curing curettage amenorrhea
CN102526373B (en) Medicinal composition for treating infantile anorexia
CN102488797B (en) Medicinal composition for treating dysmenorrhea
CN102716353A (en) Electuary for treating nephrotic syndrome
CN102805795B (en) Chinese medicinal composition for treating acute soft tissue injury of chest and hypochondrium and application thereof
CN1899401B (en) Three ingredient body comfort liquid
CN106389602A (en) Pharmaceutical composition for treating syndromes of phlegm heat and bowel repletion of stroke and preparation method of pharmaceutical composition
CN101444564A (en) Liquid medicine for treating hemorrhoids
CN103877475B (en) Oral pharmaceutical preparation for treating mania
CN104825809A (en) Medicament for treating peripheral facial paralysis
CN102671048B (en) Medicament for treating chronic urinary tract infections
CN103800733B (en) A kind of medicament treating sciatica
CN104274602B (en) Dredging collateral protects kidney wine and its preparation technology
CN103655875B (en) Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: LI XUEXIN

Free format text: FORMER OWNER: ZHANG SHIXIANG

Effective date: 20150303

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Li Xuexin

Inventor before: Zhang Shixiang

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 272100 JINING, SHANDONG PROVINCE TO: 256603 BINZHOU, SHANDONG PROVINCE

Free format text: CORRECT: INVENTOR; FROM: ZHANG SHIXIANG TO: LI XUEXIN

TA01 Transfer of patent application right

Effective date of registration: 20150303

Address after: 256603 Department of Neurosurgery, Affiliated Hospital of Binzhou Medical College, two road 661, Shandong, Binzhou, the Yellow River, China

Applicant after: Li Xuexin

Address before: Shandong Province, Jining City Health Road 272100 No. 6 of the first people's Hospital of children's rehabilitation

Applicant before: Zhang Shixiang

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150408

Termination date: 20151115

EXPY Termination of patent right or utility model